NCT00465205View on ClinicalTrials.gov

HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1 Co-infected Persons

PHASE3CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2007

Conditions
HIV InfectionsHerpes SimplexSexually Transmitted Diseases
Interventions
DRUG

Valacyclovir

500mg oral twice daily

DRUG

Matching Placebo

500 mg oral twice daily

Trial Locations (1)

Unknown

Asociacion Civil Impacta Salud y Educacion, Lima

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

collaborator

Asociación Civil Impacta Salud y Educación, Peru

OTHER

lead

University of Washington

OTHER